| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |